# Bundibugyo virus

Type: pathogen

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/bundibugyo-virus
Canonical HTML page: https://getbiobrief.com/entity/bundibugyo-virus

## Timeline

- **2026-07-11**: US aid worker tests positive — CDC confirms a US citizen aid worker in Congo has Ebola; contact tracing and containment measures initiated.
- **2026-07-08**: Record outbreak confirmed — Africa CDC reports 1,830 confirmed cases and 648 deaths, marking the fastest-growing Ebola outbreak ever recorded on the continent.
- **2026-07-01**: Clinical trials for Ebola treatment begin — Researchers launch a highly anticipated study to test experimental therapies against the Bundibugyo strain.
- **2026-06-15**: Kenya Ebola facility suspended — A Kenyan court orders suspension of construction on a US-backed isolation facility for exposed Americans, pausing Trump administration plans.
- **2026-05-22**: First US doctor infected — An American doctor working in Congo tests positive during outbreak's first week and is transferred to Germany for treatment.
- **2026-05-15**: Congo declares fresh Ebola outbreak — Authorities announce outbreak of Bundibugyo virus after weeks of undetected transmission, according to WHO.

## Recent coverage (3 stories)

### Ebola Bundibugyo Outbreak Hits 1,830 Cases: No Approved Vaccine, Trials Underway
2026-07-11 22:18:25 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

The Congo Ebola outbreak driven by the rare Bundibugyo virus has ballooned to 1,830 cases with zero approved vaccines or treatments, forcing an urgent launch of clinical trials. For biotech and pharma, this emergency opens a race to develop broad-spectrum filovirus countermeasures.
Full story: https://getbiobrief.com/story/ebola-bundibugyo-outbreak-clinical-trials

### 2 experimental drugs enter clinical trial for rare Ebola strain after 500+ deaths
2026-07-11 19:54:59 · Sentiment: Positive · Impact: 8/10 · Sources: 7

With no approved therapies for the Bundibugyo Ebola strain and an outbreak surpassing 500 fatalities, two candidate drugs have begun a clinical trial, and a prophylactic agent trial is imminent. The collaborative effort signals a pivot toward rapid, integrated R&D for neglected filoviruses.
Full story: https://getbiobrief.com/story/bio-ebola-drug-trials-bundibugyo

### Bundibugyo Ebola outbreak with no approved vaccine tops 782 cases after record spike
2026-06-15 11:52:09 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

The rare Bundibugyo Ebola virus has infected 782 people and killed 181 in Congo, with a record 72 new cases in one day. No approved vaccine or treatment exists for this strain, creating an urgent gap for biotech and pharma to address with rapid countermeasure development.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-no-vaccine-782-cases

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.